Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Policy

    Policy - Page 41

    CDSCO releases Risk classification of Medical Devices and IVDs

    CDSCO releases Risk classification of Medical Devices and IVDs

    savita thakur thakur8 Nov 2017 3:24 PM IST
    Through a recent notification, Drugs Controller General (India), Directorate General of Health Services, India's central medical device regulator, the...
    USFDA moves to more efficient global pharmaceutical manufacturing inspections

    USFDA moves to more efficient global pharmaceutical manufacturing inspections

    supriya kashyap kashyap6 Nov 2017 9:50 AM IST
    The U.S. Food and Drug Administration has determined the agency will recognize eight European drug regulatory authorities as capable of conducting...
    US states allege broad generic drug price-fixing collusion

    US states allege broad generic drug price-fixing collusion

    supriya kashyap kashyap5 Nov 2017 1:06 PM IST
    Washington: A large group of US states accused key players in the generic drug industry of a broad price-fixing conspiracy, moving to widen an earlier...
    FDA approves new treatment for adults with mantle cell lymphoma

    FDA approves new treatment for adults with mantle cell lymphoma

    supriya kashyap kashyap2 Nov 2017 12:35 PM IST
    The U.S. Food and Drug Administration granted accelerated approval to Calquence (acalabrutinib) for the treatment of adults with mantle cell lymphoma...
    Daiichi versus Ranbaxy: Singapore SC allows Harish Salve to represent the case

    Daiichi versus Ranbaxy: Singapore SC allows Harish Salve to represent the case

    savita thakur thakur2 Nov 2017 9:36 AM IST
    New Delhi: The Singapore Supreme Court has allowed the Indian lawyer Harish Salve to represent the Singh brothers Malvinder Singh and Shivinder Singh...
    Reject pressure to review price control on medical devices: Body Tells Govt

    Reject pressure to review price control on medical devices: Body Tells Govt

    Ruby Khatun Khatun26 Oct 2017 1:48 PM IST
    New Delhi: The government should reject any pressure to review price control on medical devices by the US-based medical device industry, the All India...
    Now non-essential drugs fall under price control

    Now non-essential drugs fall under price control

    Ruby Khatun Khatun23 Oct 2017 5:45 PM IST
    New Delhi: The government's push for a change in the method of price calculation methodology for new drugs can lead to non-essential drugs coming...
    No change in essential drugs ceiling price calculation: Government

    No change in essential drugs ceiling price calculation: Government

    Ruby Khatun Khatun22 Oct 2017 11:48 AM IST
    New Delhi: The government said it is not considering any changes in the methodology for calculating ceiling prices of scheduled medicines although it...
    Nurses cannot Dispense Medicines: High court turns Government order

    Nurses cannot Dispense Medicines: High court turns Government order

    Ruby Khatun Khatun17 Oct 2017 1:28 PM IST
    KOCHI: Giving their decision on the petition filed by M Sabira regarding the distribution of medicines through unqualified pharmacists, Kerala High...
    Doctors Without Borders takes Pfizer to Delhi High Court on Pneumonia Vaccine Patent

    Doctors Without Borders takes Pfizer to Delhi High Court on Pneumonia Vaccine Patent

    Ruby Khatun Khatun14 Oct 2017 1:48 PM IST
    New Delhi: A petition was filed in the Delhi High Court challenging the patent granted to US pharmaceutical company Pfizer for pneumococcal conjugate...
    NPPA issues notice to 21 hospitals over knee implant prices

    NPPA issues notice to 21 hospitals over knee implant prices

    Ruby Khatun Khatun13 Oct 2017 10:25 AM IST
    New Delhi: Drug pricing regulator NPPA has sought an explanation from 21 hospitals for not displaying on the homepage of their websites prices of knee...
    To market new drugs in India, global trials must include Indians

    To market new drugs in India, global trials must include Indians

    Ruby Khatun Khatun12 Oct 2017 3:21 PM IST
    New Delhi: The drug regulator in a recent technical committee meeting, headed by Jagdish Prasad, Director General of Health Services, has made it...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok